PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21

American Journal of Pathology

Volumn 180, Issue 5, 2012, Pages 2097-2107

  Hoefer, Julia ^a   Schfer, Georg ^a   Klocker, Helmut ^a   Erb, Holger H H ^a   Mills, Ian G ^b   Hengst, Ludger ^a   Puhr, Martin ^a   Culig, Zoran ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN INHIBITOR OF ACTIVATED SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION 1; PROTEIN P21; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; COLONY FORMATION; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN INHIBITORS OF ACTIVATED STAT; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;

EID: 84860238289     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.01.026     Document Type: Article

References (43)

1. D. Schmidt, S. Muller PIAS/SUMO: new partners in transcriptional regulation Cell Mol Life Sci 60 2003 2561 2574
2. K. Shuai Regulation of cytokine signaling pathways by PIAS proteins Cell Res 16 2006 196 202
3. C.D. Chung, J. Liao, B. Liu, X. Rao, P. Jay, P. Berta, K. Shuai Specific inhibition of Stat3 signal transduction by PIAS3 Science 278 1997 1803 1805
4. B. Liu, J. Liao, X. Rao, S.A. Kushner, C.D. Chung, D.D. Chang, K. Shuai Inhibition of Stat1-mediated gene activation by PIAS1 Proc Natl Acad Sci U S A 95 1998 10626 10631
5. C. Schindler, D.E. Levy, T. Decker JAK-STAT signaling: from interferons to cytokines J Biol Chem 282 2007 20059 20063
6. D. Ungureanu, S. Vanhatupa, N. Kotaja, J. Yang, S. Aittomaki, O.A. Jnne, J.J. Palvimo, O. Silvennoinen PIAS proteins promote SUMO-1 conjugation to STAT1 Blood 102 2003 3311 3313
7. Z. Culig Cytokine disbalance in common human cancers Biochim Biopys Acta 1813 2011 308 314
8. G. Bartsch, W. Horninger, H. Klocker, A. Pelzer, J. Bektic, W. Oberaigner, H. Schennach, G. Schfer, F. Frauscher, M. Boniol, G. Severi, C. Robertson, P. Boyle Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality BJU Int 101 2008 809 816
9. S. Detre, G. Saclani Jotti, M. Dowsett A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas J Clin Pathol 48 1995 876 878
10. A. Hobisch, R. Ramoner, D. Fuchs, S. Godoy-Tundidor, G. Bartsch, H. Klocker, Z. Culig Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype Clin Cancer Res 7 2001 2941 2948
11. D. Bello, M.M. Webber, H.K. Kleinman, D.D. Wartinger, J.S. Rhim Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18 Carcinogenesis 18 1997 1215 1223
12. H. Halfter, M. Friedrich, A. Resch, M. Kullmann, F. Stgbauer, E.B. Ringelstein, L. Hengst Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression Cancer Res 66 2006 6530 6539
13. Y. Galanty, R. Belotserkovskaya, J. Coates, S. Polo, K.M. Miller, S.P. Jackson Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks Nature 462 2009 935 939
14. M. Puhr, F.R. Santer, H. Neuwirt, M. Susani, J.A. Nemeth, A. Hobisch, L. Kenner, Z. Culig Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways Cancer Res 69 2009 7375 7384
15. W. Zhong, J. Peng, H. He, D. Wu, Z. Han, X. Bi, Q. Dai Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia Clin Invest Med 31 2008 E8 E15
16. M. Gross, B. Liu, J. Tan, F.S. French, M. Carey, K. Shuai Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells Oncogene 20 2001 3880 3887
17. S.P. Balk, K.E. Knudsen AR, the cell cycle, and prostate cancer Nucl Recept Signal 6 2008 e001
18. D.A. Frank STAT signaling in the pathogenesis and treatment of cancer Mol Med 5 1999 432 456
19. J. Suh, A.B. Rabson NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon J Cell Biochem 91 2004 100 117
20. J.W. Harper, G.R. Adami, N. Wei, K. Keyomarsi, S.J. Elledge The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 1993 805 816
21. Y. Gu, C.W. Turck, D.O. Morgan Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit Nature 366 1993 707 710
22. W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, B. Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
23. C.L. Hall, H. Zhang, S. Baile, M. Ljungman, S. Kuhstoss, E.T. Keller p21CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1 Cancer Res 70 2010 9916 9926
24. R.A. Blundell The biology of p21Waf1/Cip1: review paper Am J Biochem Biotechnol 2 2006 33 40
25. T. Abbas, A. Dutta p21 in cancer: intricate networks and multiple activities Nat Rev Cancer 9 2009 400 414
26. E.C. Brantley, L.B. Nabors, G.Y. Gillespie, Y.H. Choi, C.A. Palmer, K. Harrison, K. Roarty, E.N. Benveniste Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression Clin Cancer Res 14 2008 4694 4704
27. D. Coppola, V. Parikh, D. Boulware, G. Blanck Substantially reduced expression of PIAS1 is associated with colon cancer development J Cancer Res Clin Oncol 135 2009 1287 1291
28. P. Li, X. Yu, K. Ge, J. Melamed, R.G. Roeder, Z. Wang Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer Am J Pathol 161 2002 1467 1474
29. H.V. Heemers, K.M. Regan, L.J. Schmidt, S.K. Anderson, K.V. Ballman, D.J. Tindall Androgen modulation of coregulator expression in prostate cancer cells Mol Endocrinol 23 2009 572 583
30. S. Roy, M. Gu, K. Ramasamy, R.P. Singh, C. Agarwal, S. Siriwardana, R.A. Sclafani, R. Agarwal p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer Cancer Res 69 2009 1166 1173
31. S. Roy, M. Kaur, C. Agarwal, M. Tecklenburg, R.A. Sclafani, R. Agarwal p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells Mol Cancer Ther 6 2007 2696 2707
32. P. Chen, L. Huang, Y. Zhang, M. Qiao, Y. Yuan SiRNA-mediated PIAS1 silencing promotes inflammatory response and leads to injury of cerulein-stimulated pancreatic acinar cells via regulation of the P38MAPK signaling pathway Int J Mol Med 26 2010 619 626
33. A.L. Gartel, A.L. Tyner The role of the cyclin-dependent kinase inhibitor p21 in apoptosis Mol Cancer Ther 1 2002 639 649
34. O. Coqueret New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment Trends Cell Biol 13 2003 65 70
35. R. Kanagasabai, K. Karthikeyan, K. Vedam, W. Qien, Q. Zhu, G. Ilangovan Hsp27 protects adenocarcinoma cells from UV-induced apoptosis by Akt and p21-dependent pathways of survival Mol Cancer Res 8 2010 1399 1412
36. D. Arai, N. Nomura, K. Fukuchi, K. Gomi Cytoplasmic localization of cyclin kinase inhibitor p21 delays the progression of apoptosis Cancer Genomics Proteomics 3 2006 29 37
37. S. Nozell, X. Chen p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family Oncogene 21 2002 1285 1294
38. E. Munarriz, D. Barcaroli, A. Stephanou, P.A. Townsend, C. Maisse, A. Terrinoni, M.H. Neale, S.J. Martin, D.S. Latchman, R.A. Knight, G. Melino, V. De Laurenzi PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73 Mol Cell Biol 24 2004 10593 10610
39. W.B. Isaacs, B.S. Carter, C.M. Ewing Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles Cancer Res 51 1991 4716 4720
40. C. Zhang, X. Yuan, L. Yue, J. Fu, L. Luo, Z. Yin PIASy interacts with p73alpha and regulates cell cycle in HEK293 cells Cell Immunol 263 2010 235 240
41. H. Neuwirt, M. Puhr, I.T. Cavarretta, M. Mitterberger, A. Hobisch, Z. Culig Suppressor of cytokine signalling-3 is up-regulated by androgen and inhibits androgen-mediated proliferation and secretion Endocr Relat Cancer 14 2007 1007 1019
42. H. Neuwirt, M. Puhr, F.R. Santer, M. Susani, W. Doppler, G. Marcias, V. Rauch, M. Brugger, A. Hobisch, L. Kenner, Z. Culig Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases Am J Pathol 174 2009 1921 1930
43. A.M. De Marzo, E.A. Platz, S. Sutcliffe, J. Xu, H. Grnberg, C.G. Drake, Y. Nakai, W.B. Isaacs, W.G. Nelson Inflammation in prostate carcinogenesis Nat Rev Cancer 7 2007 256 269